{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:41:57Z","timestamp":1789587717286,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012306","name":"Universit\u00e0 degli Studi di Trieste","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012306","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Type 1 diabetes (T1D) is recognized as a complex metabolic condition associated with hormonal dysregulation and early complications. This study aimed to evaluate salivary metabolic hormones and adipokines in children and young adults with T1D, and to assess their association with early markers of metabolic and vascular complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Demographic, anthropometric, and clinical data were collected from 349 children and young adults with T1D, classified according to weight status. Salivary concentrations of metabolic hormones and adipokines were measured using a multiplex immunoassay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with normal weight (NW) individuals, overweight\/obese (OW) showed worse clinical outcomes, including higher HbA1c, lower eGFR, higher blood pressure, lower high-density lipoprotein cholesterol (HDL-C), and higher triglycerides. No differences in salivary hormone concentrations were observed according to weight status, while several hormones were significantly associated with clinical outcomes. HbA1c results inversely associated with ghrelin and glucagon-like peptide\u22121 (GLP-1) (p-value = 0.009 and p-value = 0.027, respectively), and positively with plasminogen activator inhibitor-1 (PAI-1) (p-value = 0.022). Renal function showed associations with ghrelin (p-value = 0.024), leptin (p-value &lt;0.001), and visfatin (p-value = 0.002). Blood pressure was associated with ghrelin (p-value = 0.025) and leptin (p-value = 0.039), while lipid profile parameters were associated with ghrelin (HDL-C, p-value = 0.019) and glucagon (triglycerides, p-value = 0.034).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Salivary metabolic hormones and adipokines are associated with early markers of metabolic and vascular dysfunction in young individuals with T1D, independently of weight status. These findings suggest a potential role for these biomarkers in early diabetes-related complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-03038-4","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:09:39Z","timestamp":1787998179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Salivary hormones and adipokines are associated with glycemic control and early renal and cardiometabolic markers in children and young adults with type 1 diabetes"],"prefix":"10.1007","author":[{"given":"Antonietta","family":"Robino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-3915","authenticated-orcid":false,"given":"Gianluca","family":"Tornese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Aldegheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Mozzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Morosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zanfardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bombaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Passanisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Iafusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Catamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"911","key":"3038_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2018","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW (2018) Type 1 diabetes. Lancet 383(911):69\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(13)60591-7","journal-title":"Lancet"},{"issue":"1","key":"3038_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clnu.2009.09.001","volume":"29","author":"SL Hebert","year":"2010","unstructured":"Hebert SL, Sreekumaran Nair K (2010) Protein and energy metabolism in type 1 diabetes. Clin Nutr 29(1):13\u201317. https:\/\/doi.org\/10.1016\/j.clnu.2009.09.001","journal-title":"Clin Nutr"},{"key":"3038_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1375400","volume":"11","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Li Y, Jiang W, Hou N (2024) Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy. Front Cardiovasc Med 11:1375400. https:\/\/doi.org\/10.3389\/fcvm.2024.1375400","journal-title":"Front Cardiovasc Med"},{"key":"3038_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-026-02819-1","author":"E Baldimtsi","year":"2026","unstructured":"Baldimtsi E, Ekman B, Whiss PA, Wahlberg J (2026) Influence of hormonal levels on atherosclerotic risk markers and platelet activation related to diabetic complications in patients with type 1 diabetes. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-026-02819-1","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"3038_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073330","volume":"26","author":"Y Ratan","year":"2025","unstructured":"Ratan Y, Rajput A, Pareek A, Pareek A, Singh G (2025) Comprehending the role of metabolic and hemodynamic factors alongside different signaling pathways in the pathogenesis of diabetic nephropathy. Int J Mol Sci 26(7):3330. https:\/\/doi.org\/10.3390\/ijms26073330","journal-title":"Int J Mol Sci"},{"key":"3038_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1210\/jc.2010-2363","volume":"96","author":"GV Ce","year":"2011","unstructured":"Ce GV, Rohde LE, da Silva AM, Punales MK, de Castro AC, Bertoluci MC (2011) Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory. J Clin Endocrinol Metab 96:1493\u20131499. https:\/\/doi.org\/10.1210\/jc.2010-2363","journal-title":"J Clin Endocrinol Metab"},{"key":"3038_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11892-004-0075-8","volume":"4","author":"SM Son","year":"2004","unstructured":"Son SM, Whalin MK, Harrison DG, Taylor WR, Griendling KK (2004) Oxidative stress and diabetic vascular complications. Curr Diabetes Rep 4:247\u2013252. https:\/\/doi.org\/10.1007\/s11892-004-0075-8","journal-title":"Curr Diabetes Rep"},{"issue":"4","key":"3038_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000047338","volume":"105","author":"EI Obeagu","year":"2026","unstructured":"Obeagu EI (2026) Unraveling the connection: inflammatory markers and diabetes mellitus pathogenesis. Medicine (Baltimore) 105(4):e47338. https:\/\/doi.org\/10.1097\/MD.0000000000047338","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3038_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41366-023-01429-8","volume":"48","author":"MTW Kueh","year":"2024","unstructured":"Kueh MTW, Chew NWS, Al-Ozairi E, le Roux CW (2024) The emergence of obesity in type 1 diabetes. Int J Obes (Lond) 48(3):289\u2013301. https:\/\/doi.org\/10.1038\/s41366-023-01429-8","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"3038_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1210\/er.2017-00191","volume":"39","author":"KD Corbin","year":"2018","unstructured":"Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ et al (2018) Obesity in type 1 diabetes: pathophysiology, clinical impact and mechanism. Endocr Rev 39(5):629\u2013663. https:\/\/doi.org\/10.1210\/er.2017-00191","journal-title":"Endocr Rev"},{"key":"3038_CR11","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.2147\/DMSO.S223618","volume":"14","author":"N Vilarrasa","year":"2021","unstructured":"Vilarrasa N, San Jose P, Rubio MA, Lecube A (2021) Obesity in patients with type 1 diabetes: links, risks and management challenges. Diabetes Metab Syndr Obes 14:2807\u20132827. https:\/\/doi.org\/10.2147\/DMSO.S223618","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"3038_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/endrev\/bnae032","volume":"46","author":"M Apostolopoulou","year":"2025","unstructured":"Apostolopoulou M, Lambadiari V, Roden M, Dimitriadis GD (2025) Insulin resistance in type 1 diabetes: pathophysiological, clinical, and therapeutic relevance. Endocr Rev 46(3):317\u2013348. https:\/\/doi.org\/10.1210\/endrev\/bnae032","journal-title":"Endocr Rev"},{"key":"3038_CR13","doi-asserted-by":"publisher","first-page":"5555149","DOI":"10.1155\/2021\/5555149","volume":"2021","author":"K Noras","year":"2021","unstructured":"Noras K, Rusak E, Jarosz-Chobot P (2021) The problem of abnormal body weight and dyslipidemia as risk factors for cardiovascular disease in children and adolescent with type 1 diabetes. J Diabetes Res 2021:5555149. https:\/\/doi.org\/10.1155\/2021\/5555149","journal-title":"J Diabetes Res"},{"issue":"1","key":"3038_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ijms27010027","volume":"27","author":"D Yamanouchi","year":"2025","unstructured":"Yamanouchi D (2025) The roles of incretin hormones GIP and GLP-1 in metabolic and cardiovascular health: a comprehensive review. Int J Mol Sci 27(1):27. https:\/\/doi.org\/10.3390\/ijms27010027","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3038_CR15","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181061","volume":"38","author":"Y Lv","year":"2018","unstructured":"Lv Y, Liang T, Wang G, Li Z (2018) Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism. Biosci Rep 38(5):BSR20181061. https:\/\/doi.org\/10.1042\/BSR20181061","journal-title":"Biosci Rep"},{"issue":"5","key":"3038_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051290","volume":"11","author":"VJ Clemente-Su\u00e1rez","year":"2023","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, Mart\u00edn-Rodr\u00edguez A, Mart\u00ednez-Guardado I, Navarro-Jim\u00e9nez E et al (2023) The role of adipokines in health and disease. Biomedicines 11(5):1290. https:\/\/doi.org\/10.3390\/biomedicines11051290","journal-title":"Biomedicines"},{"key":"3038_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1490143","volume":"15","author":"Y Yan","year":"2024","unstructured":"Yan Y, Wang L, Zhong N, Wen D, Liu L (2024) Multifaced roles of adipokines in endothelial cell function. Front Endocrinol (Lausanne) 15:1490143. https:\/\/doi.org\/10.3389\/fendo.2024.1490143","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"3038_CR18","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s00125-023-05956-x","volume":"66","author":"MA Nauck","year":"2023","unstructured":"Nauck MA, M\u00fcller TD (2023) Incretin hormones and type 2 diabetes. Diabetologia 66(10):1780\u20131795. https:\/\/doi.org\/10.1007\/s00125-023-05956-x","journal-title":"Diabetologia"},{"issue":"4","key":"3038_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jcjd.2017.10.040","volume":"42","author":"R Jaganathan","year":"2018","unstructured":"Jaganathan R, Ravindran R, Dhanasekaran S (2018) Emerging role of adipocytokines in type 2 diabetes as mediator of insulin resistance and cardiovascular disease. Can J Diabetes 42(4):446\u201356.e1. https:\/\/doi.org\/10.1016\/j.jcjd.2017.10.040","journal-title":"Can J Diabetes"},{"issue":"5","key":"3038_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jdiacomp.2017.02.019","volume":"31","author":"P Bjornstad","year":"2017","unstructured":"Bjornstad P, Cree-Green M, Baumgartner A, Coe G, Garcia Reyes Y, Schafer M et al (2017) Leptin is associated with cardiopulmonary fitness independent of body-mass index and insulin sensitivity in adolescents with type 1 diabetes: a brief report from the EMERALD study. J Diabetes Complicat 31(5):850\u2013853. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.02.019","journal-title":"J Diabetes Complicat"},{"issue":"4","key":"3038_CR21","doi-asserted-by":"publisher","DOI":"10.15421\/0225210","volume":"16","author":"ARM Chyad","year":"2025","unstructured":"Chyad ARM (2025) Adiponectin, leptin and novel adipokines (resistin, visfatin, omentin) as biomarkers of metabolic and immune dysregulation in type 1 diabetes. Regul Mech Biosyst 16(4):e25210. https:\/\/doi.org\/10.15421\/0225210","journal-title":"Regul Mech Biosyst"},{"issue":"8","key":"3038_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/pedi.12159","volume":"15","author":"MJ Redondo","year":"2014","unstructured":"Redondo MJ, Rodriguez LM, Haymond MW, Hampe CS, Smith EO, Balasubramanyam A et al (2014) Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatr Diabetes 15(8):543\u2013549. https:\/\/doi.org\/10.1111\/pedi.12159","journal-title":"Pediatr Diabetes"},{"issue":"21","key":"3038_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111703","volume":"22","author":"B Zy\u015bk","year":"2021","unstructured":"Zy\u015bk B, Ostrowska L, Smarkusz-Zarzecka J (2021) Salivary adipokine and cytokine levels as potential markers for the development of obesity and metabolic disorders. Int J Mol Sci 22(21):11703. https:\/\/doi.org\/10.3390\/ijms222111703","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3038_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/medicina61020243","volume":"61","author":"A Surdu","year":"2025","unstructured":"Surdu A, Foia LG, Luchian I, Trifan D, Tatarciuc MS, Scutariu MM et al (2025) Saliva as a diagnostic tool for systemic diseases - a narrative review. Medicina (Kaunas) 61(2):243. https:\/\/doi.org\/10.3390\/medicina61020243","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"3038_CR25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060640","volume":"151","author":"SE Hampl","year":"2023","unstructured":"Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF et al (2023) Executive summary: clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics 151(2):e2022060641. https:\/\/doi.org\/10.1542\/peds.2022-060640","journal-title":"Pediatrics"},{"issue":"3","key":"3038_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629\u2013637. https:\/\/doi.org\/10.1681\/ASN.2008030287","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"3038_CR27","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/pedi.12730","volume":"19","author":"C Maffeis","year":"2018","unstructured":"Maffeis C, Birkebaek NH, Kostantinova M, Schwandt A, Vazeou A, Casteels K et al (2018) Prevalence of underweight, overweight, and obesity in children and adolescent with type 1 diabetes: data from the international SWEET registry. Pediatr Diabetes 19(7):1211\u20131220. https:\/\/doi.org\/10.1111\/pedi.12730","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"3038_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13679-026-00693-9","volume":"15","author":"A Tentolouris","year":"2026","unstructured":"Tentolouris A, Koufakis T, Fousteris E (2026) Obesity in type 1 diabetes: moving beyond the \u201clean\u201d disease paradigm to understand risk, complication and treatment. Curr Obes Rep 15(1):11. https:\/\/doi.org\/10.1007\/s13679-026-00693-9","journal-title":"Curr Obes Rep"},{"key":"3038_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.06.005","volume":"394","author":"B Verg\u00e8s","year":"2024","unstructured":"Verg\u00e8s B (2024) Cardiovascular disease in type 1 diabetes, an underestimated danger: epidomiological and pathophysiological data. Atherosclerosis 394:117158. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.06.005","journal-title":"Atherosclerosis"},{"issue":"2","key":"3038_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/aoms.2013.33181","volume":"9","author":"M Coelho","year":"2013","unstructured":"Coelho M, Oliveira T, Fernandes R (2013) Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 9(2):191\u2013200. https:\/\/doi.org\/10.5114\/aoms.2013.33181","journal-title":"Arch Med Sci"},{"issue":"4","key":"3038_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jebm.12363","volume":"12","author":"LF Duffles","year":"2019","unstructured":"Duffles LF, Hermont AP, Abreu LG, Pordeus IA, Silva TA (2019) Association between obesity and adipokines levels in saliva and gingival crevicular fluid: a systematic review and meta-analysis. J Evid Based Med 12(4):313\u2013324. https:\/\/doi.org\/10.1111\/jebm.12363","journal-title":"J Evid Based Med"},{"key":"3038_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-021-00699-4","volume":"13","author":"B \u00d6zcan","year":"2021","unstructured":"\u00d6zcan B, Delhanty PJD, Huisman M, Visser JA, Neggers SJ, van der Lely AJ (2021) Overweight and obesity in type 1 diabetes is not associated with higher ghrelin concentrations. Diabetol Metab Syndr 13:79. https:\/\/doi.org\/10.1186\/s13098-021-00699-4","journal-title":"Diabetol Metab Syndr"},{"issue":"10","key":"3038_CR33","doi-asserted-by":"publisher","first-page":"E1300","DOI":"10.1152\/ajpendo.00041.2012","volume":"302","author":"I Sakata","year":"2012","unstructured":"Sakata I, Park WM, Walker AK, Piper PK, Chauang JC, Osborne-Lawrence S et al (2012) Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells. Am J Physiol Endocrinol Metab 302(10):E1300\u2013E1310. https:\/\/doi.org\/10.1152\/ajpendo.00041.2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"16","key":"3038_CR34","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.febslet.2012.06.034","volume":"586","author":"B Damdindorj","year":"2012","unstructured":"Damdindorj B, Dezaki K, Kurashina T, Sone H, Rita R, Kakei M et al (2012) Exogenus and endogenus ghrelin counteracts GLP-1 action to stimulate cAMP signaling and insulin secretion in islet \u03b2-cells. FEBS Lett 586(16):2555\u20132562. https:\/\/doi.org\/10.1016\/j.febslet.2012.06.034","journal-title":"FEBS Lett"},{"issue":"19","key":"3038_CR35","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1210\/jc.2004-0363","volume":"89","author":"C Gauna","year":"2004","unstructured":"Gauna C, Meyler FM, Janssen JAMJL, Delhanty PJD, Abribat T, van Koetsveld P et al (2004) Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 89(19):5035\u20135042. https:\/\/doi.org\/10.1210\/jc.2004-0363","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3038_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diabetes.52.1.1","volume":"52","author":"JL Evans","year":"2003","unstructured":"Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52(1):1\u20138. https:\/\/doi.org\/10.2337\/diabetes.52.1.1","journal-title":"Diabetes"},{"issue":"3","key":"3038_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.diabres.2011.08.023","volume":"94","author":"EA Hamed","year":"2011","unstructured":"Hamed EA, Zakary MM, Ahmed NS, Gamal RM (2011) Circulation leptin and insulin in obese patients with and without type 2 diabetes mellitus: relation to ghrelin and oxidative stress. Diabetes Res Clin Pract 94(3):434\u2013441. https:\/\/doi.org\/10.1016\/j.diabres.2011.08.023","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"3038_CR38","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2337\/db10-1790","volume":"60","author":"U Kielgast","year":"2011","unstructured":"Kielgast U, Holst JJ, Madsbad S (2011) Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual \u03b2-cell function. Diabetes 60(5):1599\u20131607. https:\/\/doi.org\/10.2337\/db10-1790","journal-title":"Diabetes"},{"key":"3038_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1520313","volume":"15","author":"O Resnick","year":"2025","unstructured":"Resnick O, Bril F, Beauchamp G (2025) Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer? Front Endocrinol (Lausanne) 15:1520313. https:\/\/doi.org\/10.3389\/fendo.2024.1520313","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"3038_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2183\/pjab.95.032","volume":"95","author":"T Tokudome","year":"2019","unstructured":"Tokudome T, Kangawa K (2019) Physiological significance of ghrelin in the cardiovascular system. Proc Jpn Acad Ser B Phys Biol Sci 95(8):459\u2013467. https:\/\/doi.org\/10.2183\/pjab.95.032","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"12","key":"3038_CR41","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/bjc.2016.160","volume":"114","author":"Y Yanagimoto","year":"2016","unstructured":"Yanagimoto Y, Takiguchi S, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y et al (2016) Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial. Br J Cancer 114(12):1318\u20131325. https:\/\/doi.org\/10.1038\/bjc.2016.160","journal-title":"Br J Cancer"},{"issue":"22","key":"3038_CR42","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","volume":"132","author":"AC Huby","year":"2015","unstructured":"Huby AC, Antonova G, Groenendyk J, Gomez-Sanchez CE, Bollag WB, Filosa JA et al (2015) Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation 132(22):2134\u20132145. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018226","journal-title":"Circulation"},{"issue":"10","key":"3038_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102642","volume":"10","author":"S Coimbra","year":"2022","unstructured":"Coimbra S, Rocha S, Valente MJ, Catarino C, Bronze-da-Rocha E, Belo L et al (2022) New insights into adiponectin and leptin roles in chronic kidney disease. Biomedicines 10(10):2642. https:\/\/doi.org\/10.3390\/biomedicines10102642","journal-title":"Biomedicines"},{"issue":"4","key":"3038_CR44","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/ajh\/hpv132","volume":"29","author":"CY Hsu","year":"2016","unstructured":"Hsu CY, Huang PH, Chen TH, Chiang CH, Leu HB, Huang CC et al (2016) Increased circulating visfatin is associated with progression of kidney disease in non-diabetic hypertensive patients. Am J Hypertens 29(4):528\u2013536. https:\/\/doi.org\/10.1093\/ajh\/hpv132","journal-title":"Am J Hypertens"},{"issue":"4","key":"3038_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.peptides.2004.11.008","volume":"26","author":"S Aydin","year":"2005","unstructured":"Aydin S, Halifeoglu I, Ozercan IH, Erman F, Kilic N, Aydin S et al (2005) A comparison of leptin and ghrelin levels in plasma and saliva of young healthy subjects. Peptides 26(4):647\u2013652. https:\/\/doi.org\/10.1016\/j.peptides.2004.11.008","journal-title":"Peptides"},{"issue":"2","key":"3038_CR46","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s40200-024-01488-2","volume":"23","author":"A Rossi","year":"2024","unstructured":"Rossi A, Rossi G, Montefusco L, Cimino V, Pastore I, Gandolfi A et al (2024) A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus. J Diabetes Metab Disord 23(2):2201\u20132205. https:\/\/doi.org\/10.1007\/s40200-024-01488-2","journal-title":"J Diabetes Metab Disord"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-03038-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-03038-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:09:40Z","timestamp":1787998180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-03038-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":46,"alternative-id":["3038"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-03038-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"19 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bruno Bombaci reports grants from Movi SpA and Abbott. Stefano Passanisi received speaking honoraria from Movi SpA and Sanofi. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Comitato Unico Regionale Friuli Venezia Giulia (CEUR-2018-Em-323-Burlo). Written informed consent was obtained from all participants and, in the case of minors, from their parents.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}